Evidence map›Paper›PMID 26168005›Full record

Trial reportEpidemiology and infection2016

Influenza-attributable burden in United Kingdom primary care.

D M Fleming, R J Taylor, F Haguinet, C Schuck-Paim, J Logie, D J Webb, R L Lustig, G Matias

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Epidemiology and infection, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Influenza risk groups in Norway by education and employment status.Scandinavian journal of public health · 2022
    Article
  12. Article
  13. Article
  14. Estimation of influenza-attributable burden in primary care from season 2014/2015 to 2018/2019, France.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

D M Fleming9 Dowles Close,Birmingham,UK(independent consultant).
R J TaylorSage Analytica,Bethesda,MD,USA.
F HaguinetGSK Vaccines,Wavre,Belgium.
C Schuck-PaimSage Analytica,Bethesda,MD,USA.
J LogieGSK R&D,Uxbridge,Middlesex,UK.
D J WebbGSK R&D,Uxbridge,Middlesex,UK.
R L LustigSage Analytica,Bethesda,MD,USA.
G MatiasGSK Vaccines,Wavre,Belgium.
Sage (United Kingdom) · GBGlaxoSmithKline (Belgium) · BEMiddlesex University · GBOldham Council · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Influenza is rarely laboratory-confirmed and the outpatient influenza burden is rarely studied due to a lack of suitable data. We used the Clinical Practice Research Datalink (CPRD) and surveillance data from Public Health England in a linear regression model to assess the number of persons consulting UK general practitioners (GP episodes) for respiratory illness, otitis media and antibiotic prescriptions attributable to influenza during 14 seasons, 1995-2009. In CPRD we ascertained influenza vaccination status in each season and risk status (conditions associated with severe influenza outcomes). Seasonal mean estimates of influenza-attributable GP episodes in the UK were 857 996 for respiratory disease including 68 777 for otitis media, with wide inter-seasonal variability. In an average season, 2·4%/0·5% of children aged <5 years and 1·3%/0·1% of seniors aged ⩾75 years had a GP episode for respiratory illness attributed to influenza A/B. Two-thirds of influenza-attributable GP episodes were estimated to result in prescription of antibiotics. These estimates are substantially greater than those derived from clinically reported influenza-like illness in surveillance programmes. Because health service costs of influenza are largely borne in general practice, these are important findings for cost-benefit assessment of influenza vaccination programmes.

Indexed as

Influenza A virusInfluenza B virusAdolescentAdultAgedAge FactorsAnti-Bacterial AgentsChildChild, PreschoolComorbidityDatabases, FactualDrug PrescriptionsGeneral PracticeHumansIncidenceInfantAnti-Bacterial AgentsInfluenza VaccinesEpidemiologyGP surveillance systemsinfectious diseaseinfluenzainfluenza vaccines

Identifiers

PMID26168005
PMCPMC4714299
OpenAlexW1929747309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.